Holen Sie sich die Stockscreener-App
1.43
0.70%
0.01
Schlusskurs vom Vortag:
$1.42
Offen:
$1.4
24-Stunden-Volumen:
13,921
Relative Volume:
0.82
Marktkapitalisierung:
$5.22M
Einnahmen:
$3,000
Nettoeinkommen (Verlust:
$-4.53M
KGV:
-1.154
EPS:
-1.2392
Netto-Cashflow:
$-4.69M
1W Leistung:
+3.62%
1M Leistung:
-0.69%
6M Leistung:
+6.32%
1J Leistung:
-71.46%
1-Tages-Spanne:
$1.39
$1.44
1-Wochen-Bereich:
$1.3403
$1.485
52-Wochen-Spanne:
$1.16
$5.235
Pulmatrix Inc Stock (PULM) Company Profile
Firmenname
Pulmatrix Inc
Sektor
Branche
Telefon
(888) 355-4440
Adresse
945 CONCORD STREET, FRAMINGHAM, MA
Compare PULM vs VRTX, MRNA, REGN, ARGX, ONC
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
PULM
Pulmatrix Inc
|
1.43 | 5.22M | 3,000 | -4.53M | -4.69M | -1.2392 |
VRTX
Vertex Pharmaceuticals Inc
|
514.65 | 130.44B | 12.34B | 4.34B | 3.71B | 16.87 |
MRNA
Moderna Inc
|
242.08 | 96.65B | 2.23B | -3.19B | -1.60B | -8.1462 |
REGN
Regeneron Pharmaceuticals Inc
|
807.48 | 83.13B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
869.72 | 54.69B | 4.16B | 1.29B | 734.26M | 19.58 |
ONC
Beone Medicines Ltd Adr
|
384.50 | 43.50B | 5.76B | 514.49M | 1.10B | 4.4813 |
Pulmatrix Inc Stock (PULM) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2018-02-09 | Eingeleitet | H.C. Wainwright | Buy |
Pulmatrix Inc Aktie (PULM) Neueste Nachrichten
Pulmatrix Files Eos PTC-2105 Preclinical Data Ahead of October 26 Merger Vote - Kalkine Media
Semaglutide-treated aged mice lost late-life lean mass. Pulmatrix (PULM) shares a PTC-2105 comparison. - Stock Titan
Pulmatrix Announces Third Quarter 2025 Financial Results and Divestment Plan for Migraine and Inhalation Assets - Lelezard
No resale proceeds will go to Pulmatrix (PULM) under its amended share registration. - stocktitan.net
Pulmatrix Announces $3.0 Million Registered Direct Offering - Lelezard
Pulmatrix Files Definitive Proxy for Merger with Eos SENOLYTIX, Outlines Share Issuance and Ownership Structure - Kalkine Media
Pulmatrix Sets Special Meeting to Approve Merger With Eos SENOLYTIX - TipRanks
Pulmatrix (PULM) investors face 6% stake in Eos merger - Stock Titan
Pulmatrix Inc (NASDAQ: PULM) Share Price, PULM Stock News, PULM Share Price & Updates - Kalkine
Pulmatrix (NASDAQ: PULM) warns it may liquidate if Eos merger fails - Stock Titan
Pulmatrix Inc (NASDAQ: PULM) Share Price, PULM Stock News, PULM Share Price & Updates - kalkine.ca
Pulmatrix (PULM) Holds Steady at $1.47 as Shares Trade Between Key Support and Resistance LevelsNegative Gamma - vinanet.vn
Pulmatrix | 425: Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactionsmoomoo - Moomoo
Precision Trading with Pulmatrix Inc. (PULM) Risk Zones - Stock Traders Daily
PULM Q2 2025 Earnings: Net Loss of $0.42 Per Share as Stock Moves 1.99Earnings Outlook Update - vinanet.vn
Pulmatrix (PULM) Gains 1.99% to $1.54 as Stock Holds Above Key SupportLong Term Entry Picks - vinanet.vn
PULM Q2 2025 Earnings: Loss of $0.42 Per Share Amid 3.97% Stock GainSubscription Growth Report - vinanet.vn
Form 8K Pulmatrix Inc For: 13 August By Investing.com - Investing.com Australia
Pulmatrix Announces Second Quarter 2026 Financial Results and Progress on Merger - Morningstar
Form 8K Pulmatrix Inc For: 13 August By Investing.com - Investing.com South Africa
Form 8K Pulmatrix Inc For: 13 August By Investing.com - Investing.com Nigeria
Pulmatrix Announces Second Quarter 2026 Financial Results And Progress On Merger - TradingView
Form 8K Pulmatrix Inc For: 13 August By Investing.com - Investing.com Canada
Form 8K Pulmatrix Inc For: 13 August By Investing.com - Investing.com UK
Pulmatrix posts Q2 2026 net loss $1.04M, cash $2.2M; files Form S-4 for Eos merger - TradingView
Pulmatrix, Inc. Q2 2026: Net loss $1.05M, EPS $(0.29) — 10-Q Summary - TradingView
PULM: Q2 2026 featured lower expenses, a narrowed net loss, and progress toward the Eos merger - TradingView
Press Release: Pulmatrix Announces Second Quarter 2026 Financial Results and Progress on Merger - Moomoo
Form 8K Pulmatrix Inc For: 13 August By Investing.com - Investing.com India
Pulmatrix Announces Second Quarter 2026 Financial Results and Progress on Merger - PR Newswire
Pulmatrix (PULM) Holds at $1.66 as Trading Range Between $1.58 and $1.74 Defines ActionLast Point Support - vinanet.vn
Pulmatrix Inc (PULM) Stock News Today - TradingKey
Pulmatrix Inc (PULM) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Pulmatrix (PULM) Slides 2.67% to $1.66 as Biotech Stock Tests Key Support ZoneAAII Neutral - vinanet.vn
Pulmatrix (PULM) Edges Lower to $1.65, Holds Key Support Amid Biotech ConsolidationIron Condor Alert - vinanet.vn
PULM|Pulmatrix Inc|Price:1.640|Chg%:-0.010 - TradingKey
PULM|Pulmatrix Inc|Price:1.670|Chg%:-0.060 - TradingKey
PULM|Pulmatrix Inc|Price:1.650|Chg%:-0.120 - TradingKey
Pulmatrix Inc (PULM) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Pulmatrix Inc (PULM) Cash Flow - TradingKey
Pulmatrix Inc (PULM) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
TradingKey - TradingKey
Pulmatrix Inc (PULM) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Pulmatrix Inc (PULM) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Pulmatrix Inc (PULM) Institutional Confidence - TradingKey
Pulmatrix Inc (PULM) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Pulmatrix, Inc. Revenue Breakdown – NASDAQ:PULM - TradingView
Pulmatrix Inc (PULM) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Pulmatrix Q2 2025 Earnings: Pre-Revenue Biotech Posts Net Loss as Pipeline AdvancesEPS Guidance Update - vinanet.vn
Pulmatrix Inc. (PULM) Slips 3.89% as Stock Nears Critical Support at $1.48BPI Bear Correction - dars.gov.et
Finanzdaten der Pulmatrix Inc-Aktie (PULM)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.08%
2.09%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):